Chronix Biomedical has created lab developed tests, Second Opinion™, to minimize the number of unnecessary biopsies due to cancer screen false positives.
Chronix has developed proprietary technology that measures and categorizes DNA sequences circulating in the blood that are associated with specific changes in disease and health status.